Aortic Valve Replacement Clinical Trial
Official title:
Comparison of Apixaban and Aspirin for the Prevention of Latent Bioprosthetic Valve Thrombosis After Aortic Valve Replacement Surgery: Study Protocol for a Prospective Randomized Trial
Background: The optimal antithrombotic strategy early after aortic valve replacement surgery with a biological valve remains controversial due to lack of high-quality evidence. Either oral anticoagulants or acetylsalicylic acid should be considered for the first three months. Hypo-attenuated leaflet thickening on cardiac compute tomography has been associated with latent bioprosthetic valve thrombosis and may be prevented with anticoagulation. The investigators hypothesize that anticoagulation with apixaban is superior to single antiplatelet therapy with acetylsalicylic acid in reduction of hypo-attenuated leaflet thickening of bioprosthetic valves after aortic valve replacement. Methods: In this prospective, open-label, randomized trial patients without an indication for oral anticoagulation undergoing isolated aortic valve replacement surgery with novel rapid-deployment bioprosthetic valves will be randomized. The treatment group will receive 5 mg of apixaban twice a day for the first three months and 100 mg of acetylsalicylic acid thereafter. The control group will have 100 mg of acetylsalicylic acid once a day indefinitely. After the three-month treatment period a contrast enhanced electrocardiogram-gated cardiac computed tomography will be performed to identify hypo-attenuated leaflet thickening of the bioprosthetic valve. The primary objective of the study is to assess possible superiority of the treatment group in the prevention of hypo-attenuated leaflet thickening three months after randomization. Secondary objective is to assess possible noninferiority for safety of apixaban-based strategy when compared to acetylsalicylic acid at three months. Discussion: Antithrombotic therapy after aortic valve replacement surgery is used to prevent valve thrombosis and systemic thromboembolism. Latent bioprosthetic valve thrombosis is a precursor of clinically significant prosthetic valve dysfunction or thromboembolic event. The hallmark feature of latent bioprosthetic valve thrombosis is hypo-attenuated leaflet thickening on cardiac computed tomography. Subclinical leaflet thrombosis occurs frequently in bioprosthetic aortic valves, more commonly in transcatheter than in surgical valves. There is no evidence on the effect of direct oral anticoagulants on the incidence of hypo-attenuated leaflet thickening after surgical aortic valve replacement with rapid deployment bioprostheses.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00774293 -
Homoeopathic Association in Aortic Valve Surgery
|
Phase 4 | |
Completed |
NCT05107453 -
Serratus Anterior Plane Block for Minimal Invasive Cardiac Surgery
|
Phase 4 | |
Completed |
NCT01651780 -
Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
|
Phase 3 | |
Completed |
NCT01187329 -
The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose
|
N/A | |
Recruiting |
NCT05295628 -
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
|
N/A | |
Terminated |
NCT03680040 -
RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65
|
||
Recruiting |
NCT05539937 -
Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis.
|
||
Recruiting |
NCT01522352 -
Comparison Between Three Types of Stented Pericardial Aortic Valves
|
N/A | |
Completed |
NCT01554709 -
Safety and Performance Study of the CardioGard Cannula
|
Phase 2/Phase 3 | |
Suspended |
NCT04902053 -
INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study
|
||
Completed |
NCT01404975 -
TAVI Protocol - Paravertebral Block Study
|
N/A | |
Recruiting |
NCT03889288 -
Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer
|
N/A | |
Active, not recruiting |
NCT05404880 -
INSPIRIS China PMCF Study
|
||
Recruiting |
NCT04652375 -
Outcomes After Albumin vs Lactated Ringer's Solution in CABG and AVR Procedures
|
N/A | |
Recruiting |
NCT06106451 -
Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)
|
N/A | |
Completed |
NCT00860730 -
PERCEVAL Pivotal Trial
|
N/A | |
Active, not recruiting |
NCT00396760 -
Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery
|
Phase 3 | |
Not yet recruiting |
NCT03603483 -
Aortic Root Enlargement in Aortic Valve Replacement
|
N/A | |
Terminated |
NCT01368666 -
Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark
|
N/A | |
Recruiting |
NCT03002272 -
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
|